Isolation of covalent enzyme-DNA complexes.
Rowe
T C
TC
Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, USA.
Grabowski
D
D
Ganapathi
R
R
D004247:DNA / Q000302:isolation & purification / Q000378:metabolism*; D004264:DNA Topoisomerases, Type I / Q000302:isolation & purification / Q000378:metabolism*; D004250:DNA Topoisomerases, Type II / Q000302:isolation & purification / Q000378:metabolism*; D004269:DNA, Bacterial / Q000302:isolation & purification / Q000378:metabolism; D004279:DNA, Viral / Q000302:isolation & purification / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000302:isolation & purification / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005047:Etoposide / Q000494:pharmacology; D018922:HL-60 Cells; D006801:Humans; D011485:Protein Binding; D012967:Sodium Dodecyl Sulfate / Q000494:pharmacology; D059005:Topoisomerase II Inhibitors
D004269:DNA, Bacterial; D004279:DNA, Viral; D004268:DNA-Binding Proteins; D004791:Enzyme Inhibitors; D059005:Topoisomerase II Inhibitors; D012967:Sodium Dodecyl Sulfate; D005047:Etoposide; D004247:DNA; D004264:DNA Topoisomerases, Type I; D004250:DNA Topoisomerases, Type II